Phase I Study of MLN0128 and MLN8237 in Patients With Advanced Solid Tumors and Metastatic Triple-negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Abraxane in Patients With Visceral Metastases Dominant Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Physical Activity to Maintain Quality of Life and Physical Function in Women With Metastatic Breast Cancer: a Pilot Study
- Status
- COMPLETED
- Phase
- NA
Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments
- Status
- COMPLETED
- Phase
- N/A
Vinorelbine With Trastuzumab Emtansine in Pre-Treated HER2-Positive Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Dose Escalating Study of Foxy-5 in Breast-, Colon- or Prostate Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2/PHASE3
Phase IB Study to Evaluate RAD1901 on the Availability of Estrogen Receptor Binding Sites in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Intermittent High-Dose Lapatinib in Tandem With Capecitabine for HER2 Overexpressed/Amplified Metastatic Breast Cancer With Central Nervous System (CNS) Metastases
- Status
- COMPLETED
- Phase
- PHASE1
Durvalumab in Patients With HER-2 Positive Metastatic Breast Cancer Receiving Trastuzumab
- Status
- COMPLETED
- Phase
- PHASE1
Thalidomide Plus Chemotherapy Versus Chemotherapy Alone for Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Evaluate the Safety Profile and Ability of TW1025 Oral Solution to Decrease Fatigue
- Status
- TERMINATED
- Phase
- PHASE2
Pertuzumab in First Line Treatment of HER2-positive Metastatic Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- N/A
Therapy Management With Nab-Paclitaxel in Daily Routine
- Status
- UNKNOWN
- Phase
- N/A
ACY-1215 + Nab-paclitaxel in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Characterization & Comparison of Drugable Mutations in Primary and Metastatic Tumors, CTCs and cfDNA in MBCpatients
- Status
- COMPLETED
- Phase
- N/A
Real-world Evidence Prospective Study on the Effect of Nab-paclitaxel Treatment on the Clinical Outcomes and HRQoL in Patients With MBC in Greece
- Status
- COMPLETED
- Phase
- N/A